This activity is expired and is no longer available for CME credit.


Can Sustained Release Triamcinolone Acetonide Reduce the Need for Anti-VEGF Therapy in AMD?

Author(s)/Faculty: Jennifer I. Lim, MD
Release Date: 9/14/2012Expiration Date: 9/13/2014
Credit Type: CME / ParticipationNumber of Credits: 0
Content Type: Provider:
Combination Therapy for Neovascular AMD Using PRN Ranibizumab and a Single Injection of Liquid Sustained Release Intravitreal Triamcinolone Acetonide...